On September 16, Sanofi's Shanghai Foreign R&D Innovation Center was unveiled, and Sanofi-Huashan Hospital Affiliated to Fudan University signed a cooperation agreement for the “Excellent Transformation Center”. In 2025, Sanofi's revenue was 46.7 billion euros, and China is Sanofi's second-largest market in the world. According to the plan, the center will become Sanofi's largest translational medicine research center in China, gathering global R&D capabilities to promote innovative drug research and development in key fields such as immunity, chronic diseases, tumors, and rare diseases.

On September 16, Sanofi's Shanghai Foreign R&D Innovation Center was unveiled, and Sanofi-Huashan Hospital Affiliated to Fudan University signed a cooperation agreement for the “Excellent Transformation Center”. In 2025, Sanofi's revenue was 46.7 billion euros, and China is Sanofi's second-largest market in the world. According to the plan, the center will become Sanofi's largest translational medicine research center in China, gathering global R&D capabilities to promote innovative drug research and development in key fields such as immunity, chronic diseases, tumors, and rare diseases.